Phanes Therapeutics, Inc.

Phanes therapeutics, inc. email format

Verified email-pattern data for Phanes Therapeutics, Inc. is currently limited. You can still use the company insights and contact sections below.
Phanes Therapeutics, Inc. is a clinical stage biotech company focused on innovative drug discovery and development in oncology. Currently, it is conducting three Phase I clinical trials, including the MORNINGSTAR study with its best-in-class monoclonal antibody (mAb) program, PT199, the TWINPEAK study with PT886 and the SKYBRIDGE study with PT217. Both PT886 and PT217 are first-in-class bispecific antibodies and have been granted orphan drug designation as well as Fast Track designation by the FDA. The company has built a strong pipeline by leveraging its proprietary technology platforms: PACbody®, SPECpair® and ATACCbody® to develop novel biologics that address high unmet medical needs in cancer. For more information about Phanes Therapeutics, please visit www.phanesthera.com. For business development or media inquiries, please contact bd@phanestx.com or media@phanestx.com respectively.

Company Details

Employees
27
Founded
-
Address
11535 Sorrento Valley Rd,
Industry
Biotechnology Research
HQ
San Diego, California
Looking for a particular Phanes Therapeutics, Inc. employee's phone or email?

Phanes Therapeutics, Inc. Questions

Top Phanes Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant